MEDIUM
Darktrace Enterprise Immune System before 3.1 allows CSRF via the /whitelisteddomains endpoint
Published Oct 23, 2019
6.5
MEDIUMCVSS 3.1
EPSS 1.62%
Description
Darktrace Enterprise Immune System before 3.1 allows CSRF via the /whitelisteddomains endpoint.
Affected products
No data.
- < 3.1
No data.
No Red Hat product state for this CVE.
No package ranges for this CVE.
Remediation
No remediation recorded yet.
Metrics
No CVSS v4.0 score for this CVE.
6.5 MEDIUM NVD
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:N/I:H/A:N
Attack Vector Network
Attack Complexity Low
Privileges Required None
User Interaction Required
Scope Unchanged
Confidentiality Impact None
Integrity Impact High
Availability Impact None
No CVSS v3.0 score for this CVE.
4.3 MEDIUM NVD
AV:N/AC:M/Au:N/C:N/I:P/A:N
Access Vector Network
Access Complexity Medium
Authentication None
Confidentiality Impact None
Integrity Impact Partial
Availability Impact None
This CVE is not in the KEV list.
No CISA SSVC assessment for this CVE yet.
1.62% 0.01620
Estimated probability of exploitation in the wild in the next 30 days (FIRST EPSS). As of Oct 1, 2026.
EPSS probability 0.01620
Score over time
2021–2026- EPSS v1
- EPSS v2
- EPSS v3
- EPSS v4
- EPSS v5
Percentile over time
- EPSS v1
- EPSS v2
- EPSS v3
- EPSS v4
- EPSS v5
Table of values (19 key points)
Flat stretches are collapsed; showing up to 120 newest points.
| Date | Score | Percentile | Model |
|---|---|---|---|
| Oct 1, 2026 | 1.62% (0.01620) | 75.20th | v5 (v2026.06.15) |
| Jun 15, 2026 | 1.62% (0.01620) | 72.87th | v5 (v2026.06.15) |
| Mar 30, 2025 | 2.07% (0.02074) | 82.38th | v4 (v2025.03.14) |
| Mar 29, 2025 | 5.09% (0.05091) | 82.65th | v4 (v2025.03.14) |
| Mar 28, 2025 | 2.07% (0.02074) | 82.39th | v4 (v2025.03.14) |
| Mar 27, 2025 | 5.09% (0.05091) | 88.37th | v4 (v2025.03.14) |
| Mar 20, 2025 | 2.07% (0.02074) | 82.46th | v4 (v2025.03.14) |
| Mar 19, 2025 | 5.09% (0.05091) | 88.53th | v4 (v2025.03.14) |
| Mar 17, 2025 | 1.17% (0.01171) | 77.20th | v4 (v2025.03.14) |
| Dec 12, 2024 | 0.18% (0.00184) | 57.01th | v3 (v2023.03.01) |
| Jul 10, 2023 | 0.16% (0.00159) | 51.50th | v3 (v2023.03.01) |
| Mar 7, 2023 | 0.14% (0.00137) | 47.34th | v3 (v2023.03.01) |
| Mar 6, 2023 | 4.13% (0.04134) | 86.05th | v2 (v2022.01.01) |
| Apr 1, 2022 | 4.13% (0.04134) | 84.62th | v2 (v2022.01.01) |
| Feb 4, 2022 | 4.13% (0.04134) | 68.25th | v2 (v2022.01.01) |
| Feb 3, 2022 | 4.50% (0.04504) | 76.47th | v1 |
| Jan 6, 2022 | 4.50% (0.04504) | 76.26th | v1 |
| Sep 1, 2021 | 4.50% (0.04504) | 84.13th | v1 |
| Apr 14, 2021 | 4.50% (0.04504) | 0.00th | v1 |
Weaknesses (1)
References (4)
- http://packetstormsecurity.com/files/152986/Darktrace-Enterpise-Immune-System-3.0.9-3.0.10-Cross-Site-Request-Forgery.html x_refsource_MISCExploitThird Party AdvisoryVDB Entry
- https://github.com/gerwout/CVE-2019-9596-and-CVE-2019-9597/blob/master/poc.html x_refsource_MISCExploitThird Party Advisory
- https://seclists.org/bugtraq/2019/May/54 mailing-listx_refsource_BUGTRAQExploitMailing ListThird Party Advisory
- https://www.peerlyst.com/posts/exploiting-two-zero-days-in-a-darktrace-appliance-cve-2019-9596-and-cve-2019-9597-gerwout-van-der-veen x_refsource_MISCExploitTechnical DescriptionThird Party Advisory
| Link | Providers | Tags |
|---|---|---|
| http://packetstormsecurity.com/files/152986/Darktrace-Enterpise-Immune-System-3.0.9-3.0.10-Cross-Site-Request-Forgery.html | x_refsource_MISCExploitThird Party AdvisoryVDB Entry | |
| https://github.com/gerwout/CVE-2019-9596-and-CVE-2019-9597/blob/master/poc.html | x_refsource_MISCExploitThird Party Advisory | |
| https://seclists.org/bugtraq/2019/May/54 | mailing-listx_refsource_BUGTRAQExploitMailing ListThird Party Advisory | |
| https://www.peerlyst.com/posts/exploiting-two-zero-days-in-a-darktrace-appliance-cve-2019-9596-and-cve-2019-9597-gerwout-van-der-veen | x_refsource_MISCExploitTechnical DescriptionThird Party Advisory |
Change history (0)
No recorded changes yet.
Sources
CVE.org / MITRE
Status PUBLISHED
Assigner mitre
Published Oct 23, 2019
Updated Aug 4, 2024
Reserved Mar 6, 2019
Link CVE-2019-9596
CISA Vulnrichment
Updated n/a